About ENDPOINT HEALTH

Endpoint Health is a precision immunology company dedicated to treating immune-mediated inflammatory illnesses. Leveraging its AI-powered OMNAI platform, the company develops targeted therapeutics and therapy-guiding diagnostics. It partners with pharmaceutical companies and healthcare systems to match novel treatments to the specific patients who are most likely to benefit.

Company Classification

Customers

Customer	Success Story	Source
Grifols	Entered into a global collaboration and licensing agreement with Endpoint Health to leverage its precision‑first AI platform and develop, commercialize, and license Antithrombin III and other high‑potential therapies for sepsis and other inflammatory conditions.
Henry Ford Health System	Partnered with Endpoint Health to develop and deliver precision diagnostics and therapies for critically ill patients, focusing on sepsis, by integrating Endpoint Health’s AI and genomics capabilities with Henry Ford’s clinical expertise and patient data.